Advertisement

Digestive Diseases and Sciences

, Volume 61, Issue 7, pp 1961–1971 | Cite as

Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells

  • Lei Chen
  • Yong-ze Guo
  • Ai-di Li
  • Jun-ji Ma
  • Hui-yao Hao
  • Di Zhang
  • Yan Wang
  • Chen-guang Ji
  • Wei Qi
  • Jia Wang
  • Hui-qing Jiang
Original Article

Abstract

Background

Astrocyte elevated gene-1 (AEG-1) is a positive regulator of tumorigenesis and a valuable prognostic marker of a diverse array of cancers, including liver cancer; however, the relationship between AEG-1 and hepatic fibrogenesis is not known.

Objective

The objective of this study was to explore the expression of AEG-1 during hepatic fibrogenesis and determine how AEG-1 regulates the profibrogenic phenotype of hepatic stellate cells (HSCs).

Methods

The levels of AEG-1 were monitored in the fibrotic livers and transforming growth factor-β (TGF-β)- or lipopolysaccharide (LPS)-stimulated HSCs. The expression of AEG-1 was knocked down by lentivirus-mediated short hairpin RNA in HSCs, and collagen expression, proliferation assays, apoptosis induction studies, and migration assays were simultaneously conducted in vitro.

Results

AEG-1 expression was increased in the fibrotic livers. At the cellular level, TGF-β or LPS stimulation, which caused HSC activation, induced AEG-1 expression in HSC-T6 and primary rat HSCs (P < 0.05). Knockdown of AEG-1 inhibited collagen I and α-smooth muscle actin expression (P < 0.05), reduced cell proliferation (P < 0.05) and motility (P < 0.05), and induced cell apoptosis (P < 0.05) in HSCs. This antifibrotic effect caused by lack of AEG-1 was associated with the inactivation of PI3K/Akt and the mitogen-activated protein kinase pathway.

Conclusions

Knockdown of AEG-1 suppressed the activation of HSCs by modulating the phenotype and inducing apoptosis. AEG-1 might be a potential target in treatment of hepatic fibrosis.

Keywords

Astrocyte elevated gene-1 Liver fibrosis Hepatic stellate cell Activation 

Notes

Acknowledgment

This study was supported by the National Natural Science Foundation of China (No. 81170411).

Compliance with ethical standards

Conflicts of interest

The authors declare no conflict of interest associated with this study.

References

  1. 1.
    Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.CrossRefPubMedGoogle Scholar
  2. 2.
    Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247–2250.CrossRefPubMedGoogle Scholar
  3. 3.
    Mallat A, Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol. 2013;305:C789–C799.CrossRefPubMedGoogle Scholar
  4. 4.
    Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125–172.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21:437–451.CrossRefPubMedGoogle Scholar
  6. 6.
    Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7:425–436.CrossRefPubMedGoogle Scholar
  7. 7.
    Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut. 2002;50:571–581.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803–816.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Schuppan D, Gorrell MD, Klein T, Mark M, Afdhal NH. The challenge of developing novel pharmacological therapies for nonalcoholic steatohepatitis. Liver Int. 2010;30:795–808.CrossRefPubMedGoogle Scholar
  10. 10.
    Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927–939.CrossRefPubMedGoogle Scholar
  11. 11.
    Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538–549.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008;134:657–667.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression subtraction hybridization. RaSH Oncog. 2002;21:3592–3602.CrossRefGoogle Scholar
  14. 14.
    Su ZZ, Chen Y, Kang DC, et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes inhuman fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene. 2003;306:67–78.CrossRefPubMedGoogle Scholar
  15. 15.
    Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene. 2005;353:8–15.CrossRefPubMedGoogle Scholar
  16. 16.
    Hu G, Chong RA, Yang Q, et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell. 2009;15:9–20.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Liu L, Wu J, Ying Z, et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res. 2010;70:3750–3759.CrossRefPubMedGoogle Scholar
  18. 18.
    Lee SG, Jeon HY, Su ZZ, et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene. 2009;28:2476–2484.CrossRefPubMedGoogle Scholar
  19. 19.
    Srivastava J, Siddiq A, Emdad L, et al. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model. Hepatology. 2012;56:1782–1791.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Yoo BK, Emdad L, Su ZZ, et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest. 2009;119:465–477.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Emdad L, Sarkar D, Su ZZ, et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006;66:1509–1516.CrossRefPubMedGoogle Scholar
  22. 22.
    Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA. 2006;103:17390–17395.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kikuno N, Shiina H, Urakami S, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene. 2007;26:7647–7655.CrossRefPubMedGoogle Scholar
  24. 24.
    Li J, Yang L, Song L, et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene. 2009;28:3188–3196.CrossRefPubMedGoogle Scholar
  25. 25.
    Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene. 2008;27:1114–1121.CrossRefPubMedGoogle Scholar
  26. 26.
    Emdad L, Lee SG, Su ZZ, et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc Natl Acad Sci USA. 2009;106:21300–21305.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res. 2008;68:1478–1484.CrossRefPubMedGoogle Scholar
  28. 28.
    Ma J, Li F, Liu L, et al. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009;29:567–574.CrossRefPubMedGoogle Scholar
  29. 29.
    Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010;53:132–144.CrossRefPubMedGoogle Scholar
  30. 30.
    Hu G, Wei Y, Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res. 2009;15:5615–5620.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–619.CrossRefPubMedGoogle Scholar
  32. 32.
    Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/Akt pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4:988–1004.CrossRefPubMedGoogle Scholar
  33. 33.
    Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta. 2007;1773:1161–1176.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sarkar D. AEG-1/MTDH/LYRIC in liver cancer. Adv Cancer Res. 2013;120:193–221.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Ying Z, Li J, Li M. Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond. Cell Biosci. 2011;1:36.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mohamed Suhaimi NA, Zhuo L. Imidazolium salt attenuates thioacetamide-induced liver fibrosis in mice by modulating inflammation and oxidative stress. Dig Liver Dis. 2012;44:665–673.CrossRefPubMedGoogle Scholar
  37. 37.
    Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S. Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res. 2005;29:121S–131S.CrossRefPubMedGoogle Scholar
  38. 38.
    Khuda II, Koide N, Noman AS, et al. Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology. 2009;128:e700–e706.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Yu C, Chen K, Zheng H, et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis. 2009;30:894–901.CrossRefPubMedGoogle Scholar
  40. 40.
    Li J, Zhang N, Song LB, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res. 2008;14:3319–3326.CrossRefPubMedGoogle Scholar
  41. 41.
    Yoo BK, Emdad L, Lee SG, et al. Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology. Pharmacol Ther. 2011;130:1–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Lei Chen
    • 1
  • Yong-ze Guo
    • 1
  • Ai-di Li
    • 1
  • Jun-ji Ma
    • 1
  • Hui-yao Hao
    • 2
  • Di Zhang
    • 1
  • Yan Wang
    • 1
  • Chen-guang Ji
    • 1
  • Wei Qi
    • 1
  • Jia Wang
    • 1
  • Hui-qing Jiang
    • 1
  1. 1.Department of GastroenterologyThe Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of GastroenterologyShijiazhuangChina
  2. 2.Department of Endocrinology and MetabolismThe Second Hospital of Hebei Medical UniversityShijiazhuangChina

Personalised recommendations